<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>prindictment.txt
<DESCRIPTION>PRESS RELEASE
<TEXT>
                                                                      Exhibit 99


PRESS RELEASE                       LIFE SCIENCES RESEARCH, INC.
                                    (OTCBB: LSRI)

                                    PO Box 2360
                                    Mettlers Road
                                    East Millstone, NJ 08875-2360

                                    For Further Information:
                                    Richard Michaelson
                                    Phone:   US: (732) 649-9961
                                    e-mail: LifeSciencesResearch@LSRinc.net

May 26, 2004

              LSR ANNOUNCES INDICTMENTS OF ANIMAL RIGHTS EXTREMISTS

East Millstone,  New Jersey, May 26, 2004 - Life Sciences Research, Inc. (OTCBB:
LSRI) announced today it has been informed that SHAC and the American leaders of
the animal rights  campaign  against our Company were arrested and indicted this
morning on federal charges of stalking,  conspiracy, and violation of the Animal
Enterprise Terrorism Act.

The Company is heartened by the US Department of Justice's  determination to see
justice  done.  So many people have been  victimized  by this lawless  campaign.
These  indictments  are in keeping with this nation's long tradition of standing
up to bullies and  demonstrate  the United States'  continued  determination  to
insure the safety of its people.  We welcome these actions,  and we are grateful
for the work being done by Department of Justice and the  tremendous  effort and
support  we have  seen by the FBI's  Joint  Terrorism  Task  Force and other law
enforcement agencies that have worked together on these investigations.

Life  Sciences  Research,  Inc.  is  a  global  contract  research  organization
providing product development  services to the pharmaceutical,  agrochemical and
biotechnology  industries.  LSR brings  leading  technology  and  capability  to
support its clients in  non-clinical  safety  testing of new  compounds in early
stage development and assessment.  The purpose of this work is to identify risks
to humans, animals or the environment resulting from the use or manufacture of a
wide  range of  chemicals  which  are  essential  components  of LSR's  clients'
products.   The  Company's   services  are  designed  to  meet  the   regulatory
requirements of governments  around the world. LSR operates research  facilities
in the United States (the Princeton  Research Center, New Jersey) and the United
Kingdom (Huntingdon and Eye, England).

This announcement  contains statements that may be forward-looking as defined by
the USA's Private Securities Litigation Reform Act of 1995. These statements are
based  largely on LSR's  expectations  and are  subject to a number of risks and
uncertainties,  certain  of  which  are  beyond  LSR's  control,  as more  fully
described  in the  Company's  Form 10-K for the fiscal year ended  December  31,
2003, as filed with the US Securities and Exchange Commission.

                                    -- end --

</TEXT>
</DOCUMENT>